GB0822609D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0822609D0
GB0822609D0 GB0822609A GB0822609A GB0822609D0 GB 0822609 D0 GB0822609 D0 GB 0822609D0 GB 0822609 A GB0822609 A GB 0822609A GB 0822609 A GB0822609 A GB 0822609A GB 0822609 D0 GB0822609 D0 GB 0822609D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0822609A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Respivert Ltd
Original Assignee
Respivert Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Respivert Ltd filed Critical Respivert Ltd
Priority to GB0822609A priority Critical patent/GB0822609D0/en
Publication of GB0822609D0 publication Critical patent/GB0822609D0/en
Priority to KR1020117009977A priority patent/KR20110070887A/en
Priority to US13/121,999 priority patent/US8293748B2/en
Priority to NZ591427A priority patent/NZ591427A/en
Priority to JP2011529637A priority patent/JP2012504591A/en
Priority to CN2009801395551A priority patent/CN102256964A/en
Priority to MYPI2011001435A priority patent/MY159230A/en
Priority to PE2011000797A priority patent/PE20110598A1/en
Priority to EA201170521A priority patent/EA020641B1/en
Priority to CA2738828A priority patent/CA2738828A1/en
Priority to BRPI0920707A priority patent/BRPI0920707A2/en
Priority to MX2011003553A priority patent/MX2011003553A/en
Priority to ES09785724.7T priority patent/ES2461496T3/en
Priority to PCT/GB2009/051304 priority patent/WO2010038086A2/en
Priority to EP09785724.7A priority patent/EP2350049B1/en
Priority to AU2009299555A priority patent/AU2009299555B2/en
Priority to KR1020117015760A priority patent/KR20110094130A/en
Priority to JP2011540219A priority patent/JP5670912B2/en
Priority to BRPI0922962A priority patent/BRPI0922962A2/en
Priority to PCT/GB2009/051702 priority patent/WO2010067130A1/en
Priority to CA2746354A priority patent/CA2746354A1/en
Priority to NZ593104A priority patent/NZ593104A/en
Priority to CA2746357A priority patent/CA2746357A1/en
Priority to EP09771766.4A priority patent/EP2370429B1/en
Priority to EP09768546.5A priority patent/EP2370428B1/en
Priority to CN200980156757.7A priority patent/CN102341384B/en
Priority to US13/133,998 priority patent/US8299073B2/en
Priority to MX2011006220A priority patent/MX2011006220A/en
Priority to KR1020117015734A priority patent/KR20110094127A/en
Priority to AU2009326149A priority patent/AU2009326149B2/en
Priority to JP2011540218A priority patent/JP2012511563A/en
Priority to US13/139,010 priority patent/US8299074B2/en
Priority to CN200980156810.3A priority patent/CN102333770B/en
Priority to PCT/GB2009/051703 priority patent/WO2010067131A1/en
Priority to MX2011006219A priority patent/MX2011006219A/en
Priority to AU2009326148A priority patent/AU2009326148B2/en
Priority to CO11037018A priority patent/CO6351786A2/en
Priority to CL2011000737A priority patent/CL2011000737A1/en
Priority to HN2011000876A priority patent/HN2011000876A/en
Priority to NI201100063A priority patent/NI201100063A/en
Priority to EC2011010949A priority patent/ECSP11010949A/en
Priority to ZA2011/03180A priority patent/ZA201103180B/en
Priority to CR20110477A priority patent/CR20110477A/en
Priority to HK12100606.2A priority patent/HK1160129A1/en
Priority to US13/616,696 priority patent/US8618140B2/en
Priority to US14/139,982 priority patent/US8975285B2/en
Priority to JP2014187591A priority patent/JP5959587B2/en
Ceased legal-status Critical Current

Links

GB0822609A 2008-10-02 2008-12-11 Novel compounds Ceased GB0822609D0 (en)

Priority Applications (47)

Application Number Priority Date Filing Date Title
GB0822609A GB0822609D0 (en) 2008-12-11 2008-12-11 Novel compounds
KR1020117009977A KR20110070887A (en) 2008-10-02 2009-10-02 P38 map kinase inhibitors
US13/121,999 US8293748B2 (en) 2008-10-02 2009-10-02 p38 MAP kinase inhibitors
NZ591427A NZ591427A (en) 2008-10-02 2009-10-02 P38 map kinase inhibitors
JP2011529637A JP2012504591A (en) 2008-10-02 2009-10-02 p38 MAP kinase inhibitor
CN2009801395551A CN102256964A (en) 2008-10-02 2009-10-02 Compuestos inhibidores de quinasa map p38
MYPI2011001435A MY159230A (en) 2008-10-02 2009-10-02 P38 map kinase inhibitors
PE2011000797A PE20110598A1 (en) 2008-10-02 2009-10-02 INHIBITORS OF MITOGEN P38 ACTIVATED PROTEIN KINASE ENZYMES
EA201170521A EA020641B1 (en) 2008-10-02 2009-10-02 Derivatives of n-(1-phenyl-3-alkylpyrazol-5-yl)-n'-aryl urea
CA2738828A CA2738828A1 (en) 2008-10-02 2009-10-02 P38 map kinase inhibitors
BRPI0920707A BRPI0920707A2 (en) 2008-10-02 2009-10-02 compounds
MX2011003553A MX2011003553A (en) 2008-10-02 2009-10-02 P38 map kinase inhibitors.
ES09785724.7T ES2461496T3 (en) 2008-10-02 2009-10-02 MAP p38 kinase inhibitors
PCT/GB2009/051304 WO2010038086A2 (en) 2008-10-02 2009-10-02 Novel compounds
EP09785724.7A EP2350049B1 (en) 2008-10-02 2009-10-02 P38 map kinase inhibitors
AU2009299555A AU2009299555B2 (en) 2008-10-02 2009-10-02 p38 map kinase inhibitors
KR1020117015760A KR20110094130A (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
JP2011540219A JP5670912B2 (en) 2008-12-11 2009-12-11 p38 MAP kinase inhibitor
BRPI0922962A BRPI0922962A2 (en) 2008-12-11 2009-12-11 p38 map kinase inhibitors
PCT/GB2009/051702 WO2010067130A1 (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
CA2746354A CA2746354A1 (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
NZ593104A NZ593104A (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
CA2746357A CA2746357A1 (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
EP09771766.4A EP2370429B1 (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
EP09768546.5A EP2370428B1 (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
CN200980156757.7A CN102341384B (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
US13/133,998 US8299073B2 (en) 2008-12-11 2009-12-11 P38 MAP kinase inhibitors
MX2011006220A MX2011006220A (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors.
KR1020117015734A KR20110094127A (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
AU2009326149A AU2009326149B2 (en) 2008-12-11 2009-12-11 P38 MAP kinase inhibitors
JP2011540218A JP2012511563A (en) 2008-12-11 2009-12-11 p38 MAP kinase inhibitor
US13/139,010 US8299074B2 (en) 2008-12-11 2009-12-11 P38 MAP kinase inhibitors
CN200980156810.3A CN102333770B (en) 2008-12-11 2009-12-11 P38 MAP kinase inhibitors
PCT/GB2009/051703 WO2010067131A1 (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors
MX2011006219A MX2011006219A (en) 2008-12-11 2009-12-11 P38 map kinase inhibitors.
AU2009326148A AU2009326148B2 (en) 2008-12-11 2009-12-11 p38 MAP kinase inhibitors
CO11037018A CO6351786A2 (en) 2008-10-02 2011-03-25 INKIBIDORES DE LA CINASA MAP P38
CL2011000737A CL2011000737A1 (en) 2008-10-02 2011-04-01 Compounds derived from phenyl / naphthyl-3- (1-phenyl-1h-pyrazol-5-yl) urea, mapk p38 inhibitors and low toxicity; pharmaceutical composition; and its use for the treatment of COPD, asthma, cystic fibrosis, contact dermatitis, ulcerative colitis, rheumatoid arthritis, breast carcinoma, among others.
HN2011000876A HN2011000876A (en) 2008-10-02 2011-04-01 INHIBITORS OF PROTEIN CINAZA ENZYMES ACTIVATED BY MITOGEN P38
NI201100063A NI201100063A (en) 2008-10-02 2011-04-01 INHIBITORS OF MITOGEN-ACTIVATED PROTEIN KINASE ENZYMES P38.
EC2011010949A ECSP11010949A (en) 2008-10-02 2011-04-01 INHIBITORS OF CINASE PROTEIN ENZYMES ACTIVATED BY MITOGEN P38
ZA2011/03180A ZA201103180B (en) 2008-10-02 2011-04-29 P38 map kinase inhibitors
CR20110477A CR20110477A (en) 2008-10-02 2011-09-06 PROTEIN CINASE ENZYMES INHIBITORS ACTIVATED BY MITOGEN P38
HK12100606.2A HK1160129A1 (en) 2008-10-02 2012-01-18 P38 map kinase inhibitors p38 map
US13/616,696 US8618140B2 (en) 2008-10-02 2012-09-14 P38 MAP kinase inhibitors
US14/139,982 US8975285B2 (en) 2008-10-02 2013-12-24 P38 MAP kinase inhibitors
JP2014187591A JP5959587B2 (en) 2008-12-11 2014-09-16 p38 MAP kinase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0822609A GB0822609D0 (en) 2008-12-11 2008-12-11 Novel compounds

Publications (1)

Publication Number Publication Date
GB0822609D0 true GB0822609D0 (en) 2009-01-21

Family

ID=40325938

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0822609A Ceased GB0822609D0 (en) 2008-10-02 2008-12-11 Novel compounds

Country Status (1)

Country Link
GB (1) GB0822609D0 (en)

Similar Documents

Publication Publication Date Title
GB0823467D0 (en) Novel Compounds
GB0806536D0 (en) Novel compounds
GB0800035D0 (en) Compounds
GB0813142D0 (en) Novel compounds
GB0811587D0 (en) Novel Compounds
GB0808747D0 (en) Novel compounds
IL212799A0 (en) Novel compounds
GB0812849D0 (en) Novel compounds
GB0804592D0 (en) Novel compounds
GB0810228D0 (en) Novel compounds
GB0810981D0 (en) Novel compounds
IL213032A0 (en) Novel compounds
GB0813144D0 (en) Novel compounds
GB0808030D0 (en) Novel compounds
GB0804326D0 (en) Novel compounds
GB0800411D0 (en) Novel compounds
GB0809479D0 (en) Novel compounds
GB0807050D0 (en) Novel compounds
GB0821169D0 (en) Novel compounds
GB0805272D0 (en) Novel compounds
GB0804591D0 (en) Novel compounds
GB0804585D0 (en) Novel compounds
GB0810313D0 (en) Novel compounds
GB0805273D0 (en) Novel compounds
GB0804317D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)